Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The interferon-stimulated gene RIPK1 regulates cancer cell intrinsic and extrinsic resistance to immune checkpoint blockade
Lisa Cucolo, Qingzhou Chen, Jingya Qiu, et al.
Immunity (2022) Vol. 55, Iss. 4, pp. 671-685.e10
Open Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer
Juan Dubrot, Peter P. Du, Sarah Kate Lane-Reticker, et al.
Nature Immunology (2022) Vol. 23, Iss. 10, pp. 1495-1506
Closed Access | Times Cited: 117
Tumor aerobic glycolysis confers immune evasion through modulating sensitivity to T cell-mediated bystander killing via TNF-α
Lijian Wu, Yiteng Jin, Xi Zhao, et al.
Cell Metabolism (2023) Vol. 35, Iss. 9, pp. 1580-1596.e9
Open Access | Times Cited: 89
Immunogenic cell death in cancer: targeting necroptosis to induce antitumour immunity
Pascal Meier, Arnaud J. Legrand, Dieter Adam, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 5, pp. 299-315
Closed Access | Times Cited: 81
How chemokines organize the tumour microenvironment
Thorsten R. Mempel, Julia K. Lill, Lukas M. Altenburger
Nature reviews. Cancer (2023) Vol. 24, Iss. 1, pp. 28-50
Closed Access | Times Cited: 78
Inhibition of NF-κB signaling unveils novel strategies to overcome drug resistance in cancers
Yuanfang Li, Baiwei Zhao, Juzheng Peng, et al.
Drug Resistance Updates (2024) Vol. 73, pp. 101042-101042
Open Access | Times Cited: 29
ARID1A suppresses R-loop-mediated STING-type I interferon pathway activation of anti-tumor immunity
Matthew B. Maxwell, Marianne S. Hom, Jawoon Yi, et al.
Cell (2024) Vol. 187, Iss. 13, pp. 3390-3408.e19
Closed Access | Times Cited: 26
Targeting the NF-κB pathway as a potential regulator of immune checkpoints in cancer immunotherapy
Nasim Ebrahimi, Al‐Hasnawi Rasool Riyadh Abdulwahid, Atena Mansouri, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 22
A RIPK1-specific PROTAC degrader achieves potent antitumor activity by enhancing immunogenic cell death
Jonathan Mannion, Valentina Gifford, Benjamin R. Bellenie, et al.
Immunity (2024) Vol. 57, Iss. 7, pp. 1514-1532.e15
Open Access | Times Cited: 13
Dressing Bacteria With a Hybrid Immunoactive Nanosurface to Elicit Dual Anticancer and Antiviral Immunity
Ying Liu, Mengmeng Zhang, Xinyue Wang, et al.
Advanced Materials (2022) Vol. 35, Iss. 11
Closed Access | Times Cited: 50
Roles of RIPK1 as a stress sentinel coordinating cell survival and immunogenic cell death
Jarama Clucas, Pascal Meier
Nature Reviews Molecular Cell Biology (2023) Vol. 24, Iss. 11, pp. 835-852
Closed Access | Times Cited: 29
RIPK1 inhibitors: A key to unlocking the potential of necroptosis in drug development
Yinliang Bai, Yujun Qiao, Mingming Li, et al.
European Journal of Medicinal Chemistry (2024) Vol. 265, pp. 116123-116123
Closed Access | Times Cited: 12
Plasticity-induced repression of Irf6 underlies acquired resistance to cancer immunotherapy in pancreatic ductal adenocarcinoma
Il‐Kyu Kim, Mark S. Diamond, Salina Yuan, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 11
Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
Wenhua Sang, Yiduo Zhou, Haiyan Chen, et al.
Cancer Discovery (2023) Vol. 14, Iss. 2, pp. 326-347
Closed Access | Times Cited: 18
A dual-warhead high-density lipoprotein mimetic nanomedicine simultaneously regulates stromal extracellular matrix and cGAS/STING activation for potent immunotherapy of cancer
Weiwei Wu, Gao Xiaoyang, Haina Tian, et al.
Nano Today (2025) Vol. 61, pp. 102656-102656
Closed Access
Spatial Profiling Reveals Unique Immune Microenvironment in Premenopausal Triple-Negative Breast Cancer Associated with Therapy Response
Vidya P. Nimbalkar, V. P. Snijesh, Savitha Rajarajan, et al.
Research Square (Research Square) (2025)
Closed Access
Opposing tumor-cell-intrinsic and -extrinsic roles of the IRF1 transcription factor in antitumor immunity
Prabhat Kumar Purbey, Joo-Won Seo, Manash K. Paul, et al.
Cell Reports (2024) Vol. 43, Iss. 6, pp. 114289-114289
Open Access | Times Cited: 4
A commonly inherited human PCSK9 germline variant drives breast cancer metastasis via LRP1 receptor
Wenbin Mei, Sarah J. Tabrizi, Christopher Godina, et al.
Cell (2024)
Closed Access | Times Cited: 4
Synergizing radiotherapy and immunotherapy: Current challenges and strategies for optimization
G. Rajeev-Kumar, Sean P. Pitroda
Neoplasia (2022) Vol. 36, pp. 100867-100867
Open Access | Times Cited: 19
Genetic dysregulation of immunologic and oncogenic signaling pathways associated with tumor-intrinsic immune resistance: a molecular basis for combination targeted therapy-immunotherapy for cancer
Kristian M. Hargadon
Cellular and Molecular Life Sciences (2023) Vol. 80, Iss. 2
Open Access | Times Cited: 11
Addressing Tumor Heterogeneity by Sensitizing Resistant Cancer Cells to T cell–Secreted Cytokines
Yoshinaga Ito, Deng Pan, Wubing Zhang, et al.
Cancer Discovery (2023) Vol. 13, Iss. 5, pp. 1186-1209
Open Access | Times Cited: 10
O-GlcNAcylation regulation of RIPK1-dependent apoptosis dictates sensitivity to sunitinib in renal cell carcinoma
Xiangbo Zeng, Zhiliang Chen, Yuanchao Zhu, et al.
Drug Resistance Updates (2024) Vol. 77, pp. 101150-101150
Closed Access | Times Cited: 3
The role of IFN-γ-signalling in response to immune checkpoint blockade therapy
Chun Wai Wong, Yang Huang, Adam Hurlstone
Essays in Biochemistry (2023) Vol. 67, Iss. 6, pp. 991-1002
Open Access | Times Cited: 9
The dichotomic role of single cytokines: Fine-tuning immune responses
Rafael Cardoso Maciel Costa Silva, Leonardo Holanda Travassos, Fabiano Ferreira
Cytokine (2023) Vol. 173, pp. 156408-156408
Closed Access | Times Cited: 9
FGFR1/MAPK-directed brachyury activation drives PD-L1-mediated immune evasion to promote lung cancer progression
Yunping Hu, Yong Lu, Fei Xing, et al.
Cancer Letters (2022) Vol. 547, pp. 215867-215867
Closed Access | Times Cited: 14
The role of AFAP1-AS1 in mitotic catastrophe and metastasis of triple-negative breast cancer cells by activating the PLK1 signaling pathway
Shuizhong Cen, Xiaojie Peng, Jianwen Deng, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2023) Vol. 31, Iss. 3, pp. 375-388
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top